Roux-Lombard P, Eberhardt K, Saxne T, Dayer J M, Wollheim F A
Division of Immunology and Allergy, Department of Internal Medicine, University Hospital of Geneva, 1211 Geneva 14, Switzerland.
Rheumatology (Oxford). 2001 May;40(5):544-51. doi: 10.1093/rheumatology/40.5.544.
To assess how serum concentrations of some cytokines, proteases and their inhibitors and cartilage oligomeric matrix protein (COMP) relate to the evolution of clinical disease and joint damage in early rheumatoid arthritis (RA).
Annual assessment was performed in 24 RA patients subdivided into three groups according to disease severity as determined by the radiological progression rate. All patients were followed for 5 yr after inclusion. Functional status, Larsen's radiographic index in hands and feet (joint damage score, JDS) and C-reactive protein (CRP) were assessed annually and compared with interleukin (IL)-6, IL-10, the IL-1 receptor antagonist (IL-1Ra), promatrix metalloproteinase 3 (proMMP-3), tissue inhibitor of metalloproteinases 1 (TIMP-1) and COMP, which were determined by specific immunological tests.
The median JDS was initially between 4.5 and 7. During the study time the progression of JDS was 1 (median) for patients with slow progression, 33 for patients with intermediate progression and 62 for patients with rapid progression. Changes in CRP and proMMP-3 concentrations over time differed significantly between the groups, but no significant difference was observed for IL-1Ra, TIMP-1 or COMP. ProMMP-3 was closely related to CRP at each time point. IL-6 correlated significantly with CRP at the last four annual follow-up examinations. CRP and proMMP-3 correlated with JDS at the last two or three examinations and the combined levels of these markers over 5 yr correlated significantly with joint damage progression (Spearman rank correlation 0.73 and 0.74 respectively). IL-1Ra showed a weak negative correlation with JDS, and COMP tended to correlate with JDS only at the start. The initial proMMP-3 concentration was the only significant variable predicting rapidly developing joint damage, but the predictive value was low.
ProMMP-3 correlated closely at all time points with CRP, but gave little or no additional clinical information regarding inflammation or radiographic progression. IL-1Ra and TIMP-1 showed weaker, acute-phase-like variation, which may reflect pathogenic agonist/inhibitor imbalance in the evolution of RA. COMP, in contrast, did not reflect the inflammatory CRP-related component of the disease or the destructive aspect in this study.
评估某些细胞因子、蛋白酶及其抑制剂以及软骨寡聚基质蛋白(COMP)的血清浓度与早期类风湿关节炎(RA)临床疾病演变及关节损伤之间的关系。
对24例RA患者进行年度评估,根据放射学进展率确定的疾病严重程度将其分为三组。所有患者纳入后随访5年。每年评估功能状态、手部和足部的 Larsen 放射学指数(关节损伤评分,JDS)以及 C 反应蛋白(CRP),并与通过特定免疫学检测测定的白细胞介素(IL)-6、IL-10、IL-1受体拮抗剂(IL-1Ra)、前基质金属蛋白酶3(proMMP-3)、金属蛋白酶组织抑制剂1(TIMP-1)和COMP进行比较。
JDS中位数最初在4.5至7之间。在研究期间,进展缓慢的患者JDS进展中位数为1,进展中等的患者为33,进展快速的患者为62。各组间CRP和proMMP-3浓度随时间的变化有显著差异,但IL-1Ra、TIMP-1或COMP未观察到显著差异。在每个时间点,proMMP-3与CRP密切相关。在最后四次年度随访检查中,IL-6与CRP显著相关。在最后两到三次检查中,CRP和proMMP-3与JDS相关,并且这些标志物在5年中的综合水平与关节损伤进展显著相关(Spearman等级相关性分别为0.73和0.74)。IL-1Ra与JDS呈弱负相关,而COMP仅在开始时倾向于与JDS相关。初始proMMP-3浓度是预测快速发展的关节损伤的唯一显著变量,但预测价值较低。
在所有时间点,proMMP-3与CRP密切相关,但在炎症或放射学进展方面几乎没有或没有提供额外的临床信息。IL-1Ra和TIMP-1表现出较弱的、类似急性期的变化,这可能反映了RA演变过程中致病激动剂/抑制剂的失衡。相比之下,在本研究中COMP未反映疾病中与CRP相关的炎症成分或破坏方面。